ALS Drug Development

Advance Promising Targets for Familial & Sporadic Disease, Validate Sensitive Markers of Disease Progression & Enhance Innovative Trial Design to Transform ALS Drug Development Meaningful progress in establishing causative genetic mutations and environmental factors implicated in ALS disease progression and advances in validating emerging biomarkers to evaluate treatment response has meant that the landscape for […]